Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Rigel Pharmaceuticals

Rigel Pharmaceuticals reported $-24257000 in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.

Equity Capital And Reserves Change
Agenus AGEN:US USD -58536000 2.74M
Amgen AMGN:US USD 5.35B 1.69B
Anika Therapeutics ANIK:US USD 277.59M 7.98M
Arrowhead Research ARWR:US USD 446.77M 69.73M
AstraZeneca AZN:LN USD 35.79B 1.25B
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Celldex Therapeutics CLDX:US USD 302.74M 23.46M
Daiichi Sankyo 4568:JP JPY 1.45T 31.53B
Eli Lilly LLY:US USD 11.19B 540.6M
Halozyme Therapeutics HALO:US USD 65.85M 103.95M
Heron Therapeutics HRTX:US USD -11429000 25M
Immunogen IMGN:US USD 121.92M 33.91M
Intrexon XON:US USD 184.13M 57.87M
Ionis Pharmaceuticals IONS:US USD 486.57M 86.32M
Karyopharm Therapeutics KPTI:US USD -45174000 28.52M
Ligand Pharmaceuticals LGND:US USD 646.32M 48.83M
MacroGenics MGNX:US USD 109.27M 32.74M
Neurocrine Biosciences NBIX:US USD 1.68B 23.3M
Regeneron Pharmaceuticals REGN:US USD 23.5B 831.2M
Rigel Pharmaceuticals RIGL:US USD -24257000 10.64M
Sangamo BioSciences SGMO:US USD 335.61M 40.65M
Ultragenyx Pharmaceutical RARE:US USD 220.48M 132.01M
Veracyte VCYT:US USD 1.08B 6.06M